-
For the past decade, subscribers to Contraceptive Technology Update have been asked questions about their prescribing practices. The question "In the past year, how many IUDs have you personally inserted?"
-
Conducted in a 700+ bed tertiary care, urban academic teaching hospital with a trauma center and referral center for high-risk obstetrics, this retrospective cohort study involved the procedures of 86 surgeons and 134 OB/GYNs between 1999 and 2008.
-
Conducted in a 700+ bed tÿ
-
The pendulum has been swinging away from doing early deliveries without indications, but the question remains: What is early?
-
This paper presents two parallel studies that evaluate the safety and efficacy of oral rivaroxaban in the treatment of acute deep venous thrombosis (DVT) and in continuing prophylaxis for recurrence.
-
-
In this issue: Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions.
-
Synopsis: Two years after vaginal surgery for prolapse and stress urinary incontinence, uterosacral ligament suspension and sacrospinous ligament fixation had similar outcomes. Perioperative pelvic floor muscle training did not improve urinary symptoms or prolapse symptoms.
-
Ovarian cancer causes approximately 14,000 deaths in the United States each year, making it the most common cause of gynecologic cancer death and the fifth leading cause of cancer death in women after lung, breast, colorectal, and pancreatic cancer.
-
Synopsis: A study using data from the California State Prenatal Screening Program has indicated a strong relationship between abnormal first and second trimester analyte values, as well as maternal characteristics, with placental abruption. This has stimulated a discussion of the possible benefit of retaining this type of biochemistry screening for prediction of other pregnancy complications.